美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Corgi All World 2x Daily ETF

24.41

+0.02890.12%

成交量：24

成交额：595

市值：61.03万

市盈率：- -

高：24.41

开：24.38

低：24.41

收：24.38

52周最高：25.58

52周最低：20.48

股本：2.50万

流通股本：2.50万

量比：0.23

换手率：0.10%

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

联想引爆港股硬科技，159131冲高逾4%！CXO卷土重来，华宝基金医疗ETF创6个月新高！

美银证券：中国CXO行业受惠生物科技融资强劲上调药明康德等目标价

CXO强者恒强！药明康德AH股齐升，皓元医药涨超8%！华宝基金医疗ETF（512170）涨超2%冲击五连阳

医药调研热度超越半导体！创新药回调，华宝基金港股通创新药ETF失守半年线！CXO韧性十足，药明系逆市飘红

港股异动 | CRO概念股继续走高药明康德司法取得进展有利于CXO公司在海外争取新的订单

冲高回落，CXO狂欢要散场了？

私募排排网

创新药+CXO齐发力，中报验证产业向上大趋势？

AI制药点燃“卖铲人”行情，CXO巨头刷新多项纪录！创新药接棒在即？基金经理最新解读来了！

智通港股早知道 | SK海力士批准54万亿韩元芯片扩产计划非京籍家庭购房社保个税缴纳年限下调为一年

好“药”知时节！8月创新药能否扛大旗？CXO全线爆发，华宝基金港股通医疗ETF放量劲涨5.51%

业绩的力量，CXO巨头单周暴涨20%！创新药高景气持续验证

CXO带飞医疗，华宝基金医疗ETF（512170）劲涨3%再创阶段新高！多股涨超10%，凯莱英涨停封板

港股CXO近日股价集体走高，盈警之后的泰德医药(03880)将逆市下跌还是超跌反弹？

【券商聚焦】中信建投：CXO 行业复苏明确，海内外医药投融资同步回暖

中信建投：CXO板块Beta稳中向好，AI制药大有可为

CXO巨头爆量上涨！开盘45分钟成交120亿元，超上日全天！规模最大医疗ETF（512170）创本轮反弹新高

反转信号已现，药明只是导火索

创新药产业链全线走强！CXO巨头半年净利首超百亿元，绩后飙涨逾10%！创新药龙头回暖，520880放量上探2.58%

港股异动 | CRO概念股涨幅居前近期多家海外MNC与CXO披露中报盈喜并上调全年指引

业绩炸裂！全年收入剑指605亿，药明康德AH股价狂飙！高“CXO含量”港股通医疗ETF华宝（159137）暴涨超5%！

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/WX/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"WX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WX\",,,,,undefined,":{"symbol":"WX","market":"US","secType":"STK","nameCN":"Corgi All World 2x Daily ETF","latestPrice":24.4107,"timestamp":1791921600000,"preClose":24.3818,"halted":0,"volume":24,"delay":0,"changeRate":0.0011853103544447149,"floatShares":25000,"shares":25000,"eps":0,"marketStatus":"已收盘","change":0.0289,"latestTime":"10-13 16:00:00 EDT","open":24.3818,"high":24.4107,"low":24.4107,"amount":595,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791964800000},"marketStatusCode":5,"adr":0,"exchange":"CBOE","adjPreClose":24.3818,"nav":24.48,"aum":612000,"bidAskSpread":0,"volumeRatio":0.225988},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WX\",,,,,undefined,":{"symbol":"WX","floatShares":25000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.225988,"shares":25000,"dividePrice":0,"high":24.4107,"amplitude":0,"preClose":24.3818,"low":24.4107,"week52Low":20.48,"pbRate":"--","week52High":25.58,"institutionHeld":0,"latestPrice":24.4107,"eps":0,"divideRate":0,"volume":24,"delay":0,"ttmEps":0,"open":24.3818,"prevYearClose":24.72,"prevWeekClose":24.4952,"prevMonthClose":23.9994,"prevQuarterClose":23.9994,"fiveDayClose":24.8004,"twentyDayClose":24.0016,"sixtyDayClose":23.5672},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/WX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"WX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"WX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"WX\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659315910","title":"联想引爆港股硬科技，159131冲高逾4%！CXO卷土重来，华宝基金医疗ETF创6个月新高！","url":"https://stock-news.laohu8.com/highlight/detail?id=2659315910","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659315910?lang=zh_cn&edition=fundamental","pubTime":"2026-08-13 19:20","pubTimestamp":1786620000,"startTime":"0","endTime":"0","summary":"联想集团炸裂财报催化，同类规模最大、流动性最强*的港股通信息技术ETF华宝场内价格一度冲高逾4%，收涨2.99%强势连阳。CXO卷土重来，全市场规模最大医疗ETF华宝盘中最高涨至2.86%上探创近6个月新高，收涨1.43%豪取五连阳。联想集团飙升19%创新高！值得注意的是，港股通信息技术权重股联想科技一度涨超19%创历史新高。CXO再度领衔，华宝基金医疗ETF逆市创6个月新高！底层资产是港股，高弹性，T+0。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-08-13/doc-inineqhp9946806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159828","IE00B0JY6N72.USD","HK0000306701.USD","LU0543330483.HKD","CXO","00992","LU0264606111.USD","BK1526","LNVGY","HK0000320223.HKD","LU1267930227.SGD","LU0049112450.USD","LU0048580855.USD","LU0310800965.SGD","IE0003895053.USD","LU0862451753.SGD","WX","LU0029875118.USD","03441","LU1046422090.SGD","KCAI","LU0128525689.USD","LU0320764755.SGD","LU0791590937.USD","VXUS","LU0128522157.USD","LU1366334651.USD","LU0052756011.USD","BK4585","HK0000306685.HKD","TCHI","LU0572940350.SGD","LU0862451837.USD","LU2242644610.SGD","IE0034224299.USD","IE0032431581.USD","159131","80992","LU0572939691.SGD","LU0791591158.USD","LU0672654166.SGD","BK4588","BK1607","LU1235295612.USD","LU0890818403.SGD","BK1193","LU0370786039.SGD","HK0000320264.USD","LU1366334578.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659138517","title":"美银证券：中国CXO行业受惠生物科技融资强劲 上调药明康德等目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=2659138517","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659138517?lang=zh_cn&edition=fundamental","pubTime":"2026-08-13 12:41","pubTimestamp":1786596060,"startTime":"0","endTime":"0","summary":"模拟交易客户端美银证券发布研报称，受惠上半年全球及中国生物科技一级市场融资表现强劲，加上创新药对外授权交易持续活跃，预期研发活动将进一步加快，中国CRO/CDMO企业可望受惠。该行上调药明康德H股目标价由204.3港元至242港元，药明康德A股目标价由177.8元人民币至210.5元人民币，维持“买入”评级，因其增长能见度清晰。该行并上调药明康德2029至2035年收入估算介乎3%至7%，经调整纯利预测亦上调介乎3%至7%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2026-08-13/doc-inincxku3329313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["WX","PSIL","IBRN","BBC","IDNA","XBIX","MEDI","FHLC","SMCO","BMED","CXO","APXH","02359","161027","SURI","603259","PSCH","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659187744","title":"CXO强者恒强！药明康德AH股齐升，皓元医药涨超8%！华宝基金医疗ETF（512170）涨超2%冲击五连阳","url":"https://stock-news.laohu8.com/highlight/detail?id=2659187744","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659187744?lang=zh_cn&edition=fundamental","pubTime":"2026-08-13 11:25","pubTimestamp":1786591500,"startTime":"0","endTime":"0","summary":"8月13日，AH医疗板块迅速反弹。CXO强者恒强，药明康德AH股双双涨逾1%，康龙化成AH股齐升逾4%，A股皓元医药涨超7%。场内高CXO含量ETF同步走走强，CXO含量超50%的港股通医疗ETF华宝涨逾1%。全市场规模最大医疗ETF华宝CXO含量超30%，盘中涨超2%冲击五连阳，成交超4.5亿元。紧跟医疗反攻行情，关注两大“利器”：港股通医疗ETF华宝：最新CXO含量达51.88%，其中药明系权重占比超38%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-08-13/doc-ininctaw3414344.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0611395673.USD","LU1251922891.USD","LU2488822045.USD","LU2328871848.SGD","LU2495084118.USD","LU1969619763.USD","LU2125910500.SGD","BK1583","LU1997245094.SGD","LU1979443071.USD","IE00BPRC5H50.USD","LU0708995583.HKD","02359","LU0348766576.USD","LU0456842615.SGD","BK1576","LU0700851271.USD","IE00B5MMRT66.SGD","LU2045819591.USD","WX","603259","LU1719994722.HKD","LU1808992512.USD","LU1997245177.USD","LU1770034418.SGD","LU1934453819.USD","159828","BK1141","BK0216","LU0348767384.USD","IE00B543WZ88.USD","LU1046422090.SGD","LU0052750758.USD","688131","LU0320764599.SGD","LU1997244956.HKD","512170","LU1303224171.USD","LU2242644610.SGD","CXO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658288069","title":"医药调研热度超越半导体！创新药回调，华宝基金港股通创新药ETF失守半年线！CXO韧性十足，药明系逆市飘红","url":"https://stock-news.laohu8.com/highlight/detail?id=2658288069","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658288069?lang=zh_cn&edition=fundamental","pubTime":"2026-08-12 11:02","pubTimestamp":1786503720,"startTime":"0","endTime":"0","summary":"业绩兑现叠加AI制药概念加持，CXO韧性十足，药明生物、药明康德、药明合联逆市飘红，金斯瑞生物科技续涨逾1%。港股通创新药龙头股批量飘绿，百济神州跌2%止步6连阳，翰森制药跌逾3%；再鼎医药延续涨势，股价创年内新高。100%创新药研发标的——港股通创新药ETF华宝冲高回落，现跌1%再失半年线。8月以来，创新药及产业链利好密集，“吃药”行情持续上演。同期医药生物行业的市场关注度大幅攀升。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-08-12/doc-inimzqcp6895872.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LNGR","SOXS","BK4588","TECY","159316","SMHU","EIS","06978","CXO","MQQQ","BK1574","CHPY","SOXQ","NBDS","09939","159938","BK4585","CWC","VGT","BK1161","MEDX","IBBQ","159582","SOXX","XSD","SOXY","PSI","FLHK","USD","159992","FTXL","SMH","CHPS","FWD","TEKX","SMHX","BK4535","WX","SSG","BK1515","SOXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658096997","title":"港股异动 | CRO概念股继续走高 药明康德司法取得进展 有利于CXO公司在海外争取新的订单","url":"https://stock-news.laohu8.com/highlight/detail?id=2658096997","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658096997?lang=zh_cn&edition=fundamental","pubTime":"2026-08-11 11:47","pubTimestamp":1786420064,"startTime":"0","endTime":"0","summary":"消息面上，CRO行业近期迎来多重利好。药明康德司法进展：暂缓美国国防部针对公司的1260H认定执行。药明康德、百济神州等医药行业龙头公布中期业绩大幅增长。药明康德司法进展事件，有利于CXO公司在海外争取新的订单。中国创新药出海持续超预期，充分验证了中国创新药资产的全球竞争力。我们坚定看好创新药产业链的行业前景，建议关注创新药管线有全球竞争力并有大额BD落地或预期的公司、业绩快速增长的CXO公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478382.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0700851271.USD","LU1251922891.USD","LU1719994722.HKD","LU1969619763.USD","BK1141","CXO","LU2328871848.SGD","LU0348766576.USD","LU0320764599.SGD","06127","LU1997245094.SGD","LU1934453819.USD","LU0052750758.USD","HK0000306701.USD","LU0708995583.HKD","BK1576","LU1770034418.SGD","IE00B5MMRT66.SGD","03759","BK4585","LU1046422090.SGD","LU0456842615.SGD","LU2125910500.SGD","LU2242644610.SGD","KCAI","BK4588","LU2045819591.USD","BK1583","LU1997245177.USD","01548","02359","IE00B543WZ88.USD","LU1979443071.USD","WX","LU1303224171.USD","LU2488822045.USD","LU1997244956.HKD","HK0000320223.HKD","HK0000320264.USD","LU2495084118.USD","LU1808992512.USD","HK0000306685.HKD","VXUS","IE00BPRC5H50.USD","BK0216","LU0611395673.USD","LU0348767384.USD","603259"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658936871","title":"冲高回落，CXO狂欢要散场了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2658936871","media":"私募排排网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658936871?lang=zh_cn&edition=fundamental","pubTime":"2026-08-10 19:09","pubTimestamp":1786360140,"startTime":"0","endTime":"0","summary":"整个盘面看下来，CXO这条线热度还在，但短期资金明显开始犹豫了。放到整个CXO行业来说，基本面确实也在回暖。因此，全球创新药融资与大药企研发投入是CXO订单和业绩的核心指标。不过值得注意的是，从6月上旬到现在，CXO板块反弹超35%，创新药概念板块也涨了15%多，短期获利盘应该不少，短期可能有颠簸。CXO这出戏，应该还没到散场的时候。笔者结合公募二季度持仓数据，梳理了基金重仓的CXO公司情况，供读者参考。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-10/doc-inimvsvi8100500.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["WX","CXO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658982630","title":"创新药+CXO齐发力，中报验证产业向上大趋势？","url":"https://stock-news.laohu8.com/highlight/detail?id=2658982630","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658982630?lang=zh_cn&edition=fundamental","pubTime":"2026-08-10 17:41","pubTimestamp":1786354860,"startTime":"0","endTime":"0","summary":"截至8月7日，已有22家创新药上市公司发布今年上半年业绩相关报告且普遍向好，其中同比增长的有12家，扭亏的有3家，还有1家减亏。截至8月7日，A股CRO板块中已有8家企业披露半年报或业绩预告，其中6家业绩有望实现两位数及以上增长。结合机构研报，本轮创新药及CXO板块业绩显著提速，主要得益于以下四方面因素的共振。2026年上半年，多家创新药企依托大单品实现销售收入持续放量，验证了企业自建商业化体系的能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjh/2026-08-10/doc-inimvnpp4945765.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IBBQ","LNGR","WX","159992","06978","MEDX","BK1161","BK1574","CXO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658825039","title":"AI制药点燃“卖铲人”行情，CXO巨头刷新多项纪录！创新药接棒在即？基金经理最新解读来了！","url":"https://stock-news.laohu8.com/highlight/detail?id=2658825039","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658825039?lang=zh_cn&edition=fundamental","pubTime":"2026-08-10 17:41","pubTimestamp":1786354860,"startTime":"0","endTime":"0","summary":"8月以来，港股创新药产业链再起攻势，CXO强势领衔！与此同时，公募医药仓位降至5年冰点，低配状态下易引发扩散性行情。】 AI制药关注度升温，CXO或率先受益。港股金斯瑞生物科技的基因合成、定制化蛋白业务受益AI制药需求提升，中报有望上调全年指引。CXO之后，创新药有望接力行情。预计今年随着商业化端和BD端的推动，行业将普遍盈利超预期兑现，叠加Q3、Q4可能的BD，以及与AI相关的合作，后续创新药有望接棒CXO开启新一轮行情。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-08-10/doc-inimvnpi1271075.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AGIX","BK1191","CHAT","CXO","IBBQ","159992","LNGR","VTHR","06978","WX","AIPO","QTOC","ARTY","MEDX","BK1161","BK1574","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658064603","title":"智通港股早知道 | SK海力士批准54万亿韩元芯片扩产计划 非京籍家庭购房社保个税缴纳年限下调为一年","url":"https://stock-news.laohu8.com/highlight/detail?id=2658064603","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658064603?lang=zh_cn&edition=fundamental","pubTime":"2026-08-10 07:20","pubTimestamp":1786317636,"startTime":"0","endTime":"0","summary":"公司对法院批准公司所申请的初步禁令的裁决表示欢迎。SK海力士批准54万亿韩元芯片扩产计划！调整后，非京籍家庭在全市范围内购买商品住房的社保或个税缴纳年限统一为“1年”，购买商品住房的套数保持不变。《通知》自8日起实施。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477731.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SKHY","600988","BK1589","BK4141","BK1144","BK1515","SK","07709","SKUU","SKHZ","03330","BK1592","SKHU","SKHX","03677","06693","WX","601211","IE00BZ08YR35.GBP","SKHYV","BK1147","SBHMY","02611","01788","BK1116","SKDD","01177","IE00BZ08YS42.EUR","BK1191","BK1564","HK0000165453.HKD","HYNX","02480","02889","BK1161","BK1544","IE00BZ08YT58.USD","BK1198","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658672913","title":"好“药”知时节！8月创新药能否扛大旗？CXO全线爆发，华宝基金港股通医疗ETF放量劲涨5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658672913","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658672913?lang=zh_cn&edition=fundamental","pubTime":"2026-08-09 19:28","pubTimestamp":1786274880,"startTime":"0","endTime":"0","summary":"尾盘阶段，权重股中际旭创突发跳水，收跌逾3.5%，单日振幅超10%。AH近20股涨超10%，药明康德H股新高，华宝基金港股通医疗ETF放量涨5.51%！医药“炸场”，创新药链全线爆发，港股通医疗ETF华宝、港股通创新药ETF华宝、医疗ETF华宝、药ETF华宝等相关ETF批量大涨！CXO龙头集体猛攻，批量涨超10%！港股通医疗ETF华宝放量劲涨5.51%，标的指数近5成仓位布局CXO龙头，其中药明系权重超35%。随着中报季及创新药管线催化预期到来，持续看好医药后市。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-08-09/doc-inimtpwf1700745.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06978","LNGR","BK1161","159828","CXO","IBBQ","WX","BK1574","MEDX","FLHK","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657648344","title":"业绩的力量，CXO巨头单周暴涨20%！创新药高景气持续验证","url":"https://stock-news.laohu8.com/highlight/detail?id=2657648344","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657648344?lang=zh_cn&edition=fundamental","pubTime":"2026-08-07 19:25","pubTimestamp":1786101900,"startTime":"0","endTime":"0","summary":"8月5日，药明康德A股单日成交197.4亿元创历史天量；8月7日，其H股跳涨7%创历史新高，A股涨8.49%创5年新高。当周，药明康德AH股涨幅分别高达20.55%、19.66%。龙头大哥药明康德携多家CXO企业已经用业绩和订单证明行业景气度，创新药企能否同样用超预期业绩来完成产业共振的双向验证。全球创新药投融资回暖。中国创新药BD持续爆发。相关ETF港股通医疗 ETF 华宝：重仓创新药产业链，48%CXO+20%创新药，其中药明系占比超35%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-08-07/doc-inimnzsc3113279.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CXO","06978","159992","BK1161","BK1574","MEDX","WX","LNGR","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657202693","title":"CXO带飞医疗，华宝基金医疗ETF（512170）劲涨3%再创阶段新高！多股涨超10%，凯莱英涨停封板","url":"https://stock-news.laohu8.com/highlight/detail?id=2657202693","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657202693?lang=zh_cn&edition=fundamental","pubTime":"2026-08-07 11:21","pubTimestamp":1786072860,"startTime":"0","endTime":"0","summary":"8月7日，CXO再爆发！博腾股份、皓元医药、康龙化成集体涨超10%，凯莱英涨停封板，权重龙头药明康德涨超5%再创3年新高！全市场规模最大医疗ETF华宝反包大涨3%，场内价格再创本轮反弹新高！数据显示，医疗ETF华宝标的指数覆盖8只CXO龙头股，权重合计近30%。高效参与CXO交易，关注两大“利器”：医疗ETF华宝：全市场规模最大医药医疗类ETF，聚焦医疗器械+医疗服务，兼顾AI医疗概念。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-08-07/doc-inimnenr0085901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","06821","512170","002821","BK0239","159891","LU1328615791.USD","WX","CXO","159828","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657698357","title":"港股CXO近日股价集体走高，盈警之后的泰德医药(03880)将逆市下跌还是超跌反弹？","url":"https://stock-news.laohu8.com/highlight/detail?id=2657698357","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657698357?lang=zh_cn&edition=fundamental","pubTime":"2026-08-07 10:22","pubTimestamp":1786069332,"startTime":"0","endTime":"0","summary":"7月31日盘后，泰德医药发布了其26H1财年盈警公告。目前泰德医药尚未迎来连续数个交易日的低点逐步抬高以彻底终结下跌趋势，关键的量能均线也尚未出现明显转折。近日，港股医药概念股集体走高，CXO、创新药板块多点爆发，带动恒生医疗保健指数强势反弹。以8月4日行情为例，港股CXO板块出现一波个股集体走高，其中药明康德股价大涨11.17%，康龙化成和泰格医药均涨超5%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477144.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CXO","03880","BK4585","KCAI","NIFE","BK1141","VXUS","WX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657657002","title":"【券商聚焦】中信建投：CXO 行业复苏明确，海内外医药投融资同步回暖","url":"https://stock-news.laohu8.com/highlight/detail?id=2657657002","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657657002?lang=zh_cn&edition=fundamental","pubTime":"2026-08-06 09:04","pubTimestamp":1785978243,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投表示，国内CXO行业经历22-24年的调整阶段后，受益海外投融资率先回暖，24年国内头部CXO公司海外订单展现复苏态势，随着25年国内创新药资产实现大规模对外授权，带动国内投融资25H2持续复苏，行业内需同样企稳回升。26年至今国内创新药行业的长期结构性机会持续兑现，国内投融资持续改善，新药物形式赛道持续火热并进一步放量，该机构认为26年国","market":"other","thumbnail":"https://static.szfiu.com/news/20250106/ODRhMzI4MWM5YTc2MTY1NjgxNGQwMTEwODUwOTcyNzQ0Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ODRhMzI4MWM5YTc2MTY1NjgxNGQwMTEwODUwOTcyNzQ0Mg==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987586","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WX","BK1515","BK0276","601066","CXO","09939","BK1161","159938","KCE","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657572212","title":"中信建投：CXO板块Beta稳中向好，AI制药大有可为","url":"https://stock-news.laohu8.com/highlight/detail?id=2657572212","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657572212?lang=zh_cn&edition=fundamental","pubTime":"2026-08-06 07:41","pubTimestamp":1785973273,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AIPO","QTOC","VTHR","CXO","CHAT","ARTY","AGIX","WX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657591587","title":"CXO巨头爆量上涨！开盘45分钟成交120亿元，超上日全天！规模最大医疗ETF（512170）创本轮反弹新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2657591587","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657591587?lang=zh_cn&edition=fundamental","pubTime":"2026-08-05 10:35","pubTimestamp":1785897300,"startTime":"0","endTime":"0","summary":"CXO巨头药明康德重磅财报继续发酵！8月5日早盘，药明康德A股爆量上行，盘初一度续涨逾6%，截至10：15涨4.6%，成交超120亿元，超越上日全天，跻身A股成交额前五！全市场规模最大医疗ETF华宝同步上扬，场内价格创本轮反弹新高！数据显示，药明康德为医疗ETF华宝第一大重仓股，最新持仓占比达12.69%。高效参与CXO交易，关注两大“利器”：医疗ETF华宝：全市场规模最大医药医疗类ETF，聚焦医疗器械+医疗服务，兼顾AI医疗概念。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-08-05/doc-inimfshm5200987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CXO","159828","WX","512170"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657619592","title":"反转信号已现，药明只是导火索","url":"https://stock-news.laohu8.com/highlight/detail?id=2657619592","media":"虎嗅APP","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657619592?lang=zh_cn&edition=fundamental","pubTime":"2026-08-05 07:58","pubTimestamp":1785887880,"startTime":"0","endTime":"0","summary":"2026年2季度，共有793个机构投资者披露持有药明康德A股，合计持股量达10.93亿股，占总股本的36.64%。2026年6月末，药明康德有664.3亿元的在手订单，同比增长25.2%，超1季度23.6%的增幅。行业反转信号现，药明只是导火索此前市场对CXO行业最大的疑虑是“订单有改善，但利润没出来”，但2026年中报正在打破这个质疑。2026年6月8日，药明康德被新增列入。药明康德已于6月11日提起诉讼，目前尚未裁决。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MTQzMjE1NjQwMQ==&mid=2656191578&idx=3&sn=832b803cb4237ffa6df707ef821c3501&chksm=671c8735cca01ad5e39d65b82e0f5f3051390a006108bde4292a28549d69473cd36634de313a&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["WX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656589128","title":"创新药产业链全线走强！CXO巨头半年净利首超百亿元，绩后飙涨逾10%！创新药龙头回暖，520880放量上探2.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656589128","media":"新浪基金","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656589128?lang=zh_cn&edition=fundamental","pubTime":"2026-08-04 11:07","pubTimestamp":1785812820,"startTime":"0","endTime":"0","summary":"8月4日早盘，创新药产业链全线走强，港股一马当先！港股通创新药龙头多股回暖，百济神州、石药集团、康方生物、中国生物制药等批量涨超1%，100%创新药研发标的——港股通创新药ETF华宝盘初放量上探2.58%！CXO巨头药明康德半年度业绩大增，绩后跳空高开，港股股价一度暴涨超14%！8月3日晚间，药明康德披露了上半年业绩，超出市场预期。这是公司净利润首次在上半年突破百亿元大关。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-08-04/doc-inimchzm4203295.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IBBQ","520880","MEDX","WX","LNGR","BK1574","BK1161","159992","06978","CXO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656158919","title":"港股异动 | CRO概念股涨幅居前 近期多家海外MNC与CXO披露中报盈喜并上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2656158919","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656158919?lang=zh_cn&edition=fundamental","pubTime":"2026-08-04 11:05","pubTimestamp":1785812703,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，CRO概念股涨幅居前，截至发稿，药明康德涨11.05%，报180.9港元；金斯瑞生物科技涨10.18%，报17.96港元；凯莱英涨7.71%，报117.4港元；药明生物涨3.92%，报40.34港元。消息面上，药明康德公告称，上半年公司实现营业收入288.97亿元，同比增长38.93%；归母净利润110.8亿元，同比增长29.43%。值得注意的是，近期已有多家多家海外MNC与CXO披露中报盈喜并上调全年指引。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475611.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0823426480.USD","LU0979878070.USD","LU0043850808.USD","BK1191","LU1242518931.SGD","LU0181495838.USD","HK0000306685.HKD","LU0140636845.USD","LU0456827905.SGD","LU0856984785.SGD","LU1688375341.USD","BK1610","02359","LU0516422440.USD","BK1583","LU0052750758.USD","LU0327786744.USD","LU1046422090.SGD","LU0708995583.HKD","BK1589","KCAI","BK1141","LU1794554557.SGD","LU0348766576.USD","BK4588","KURE","LU0417516738.SGD","LU0516423174.USD","LU1720050803.USD","LU0039217434.USD","06821","LU3063872942.SGD","LU0417516902.SGD","LU0456846285.SGD","CXO","BK4585","01548","LU0348767384.USD","SG9999002463.SGD","LU1242518857.USD","LU0348825331.USD","BK1521","LU0588546209.SGD","WX","BK1576","LU0359202008.SGD","HK0000306701.USD","VXUS","02269","LU0516422952.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656958656","title":"业绩炸裂！全年收入剑指605亿，药明康德AH股价狂飙！高“CXO含量”港股通医疗ETF华宝（159137）暴涨超5%！","url":"https://stock-news.laohu8.com/highlight/detail?id=2656958656","media":"新浪基金","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656958656?lang=zh_cn&edition=fundamental","pubTime":"2026-08-04 09:47","pubTimestamp":1785808020,"startTime":"0","endTime":"0","summary":"药明康德业绩炸裂，CXO板块大受提振！8月4日早盘，药明康德AH股跳空高开，携手狂飙，A股涨停封板，港股一度暴涨超14%。港股通医疗ETF华宝近5成仓位布局CXO，场内价格一度暴涨超5%！全市场规模最大医疗ETF华宝CXO含量近30%，现涨超2%。8月3日晚，药明康德发布半年报，公司上半年实现营业收入288.97亿元，同比增长38.93%；归属于上市公司股东的净利润110.8亿元，同比增长29.43%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-08-04/doc-inimchzm4134226.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CXO","LU2495084118.USD","LU1303224171.USD","LU0348767384.USD","LU1046422090.SGD","LU2242644610.SGD","LU1808992512.USD","512170","FLHK","IE00B543WZ88.USD","LU0611395673.USD","LU0320764599.SGD","LU0456842615.SGD","BK1141","BK1583","LU1997245177.USD","WX","LU0348766576.USD","IE00B5MMRT66.SGD","BK1576","LU1997244956.HKD","LU2125910500.SGD","LU1251922891.USD","LU2328871848.SGD","LU0052750758.USD","LU2488822045.USD","BK0216","IE00BPRC5H50.USD","LU0708995583.HKD","02359","LU1934453819.USD","159137","LU1997245094.SGD","603259","LU1969619763.USD","LU1719994722.HKD","LU0700851271.USD","LU2045819591.USD","LU1770034418.SGD","LU1979443071.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":65,"code":"91000000","status":"200"}]}}